GlassScriptPhysician profile
Lisa Schavrien
NPI 1851551360
$1,887.39
in general payments reported to CMS, 2019-2025
20 companies · $559 in 2025
The $559 reported for 2025 was more than what 82% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $196 · 2023: $389 · 2024: $530 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,477.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $555.75 | 2022-2025 | Floseal, Perclot |
| Bioventus LLC | $182.02 | 2023-2024 | Signafuse |
| Medtronic, INC. | $162.96 | 2025 | Kyphon Express II Kyphopak Tray, Cd Horizon Spinal System |
| Boston Scientific Corporation | $149.15 | 2023 | |
| Abbott Laboratories | $144.85 | 2023 | Freestyle Libre |
| Horizon Therapeutics Plc | $123.68 | 2021 | |
| Ethicon US, LLC | $104.35 | 2025 | Surgiflo Hemostatic Matrix, Stratafix, Vistaseal |
| Gilead Sciences, INC. | $96.16 | 2024 | Epclusa |
| Medical Device Business Services, INC. | $72.49 | 2025 | Surgiflo Hemostatic Matrix |
| Si-Bone, INC. | $52.06 | 2022-2023 | |
| Globus Medical, INC. | $51.57 | 2025 | Senza, Reline |
| Olympus America INC. | $39.27 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $30.27 | 2021-2024 | Andexxa |
| Stryker Corporation | $24.10 | 2022 | |
| Scilex Pharmaceuticals INC. | $20.61 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.03 | 2025 | |
| Nevro Corp. | $16.16 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.92 | 2021 | |
| Novocure INC. | $14.30 | 2024 | Optune |
| Convatec INC. | $13.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Schavrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.